Showing 1–12 of 24 results

Enbrel

300,00 332,00 

Therapeutic TNF-α-inhibitor from the original Enbrel commercial drug targeting the TNF-α-antigen.

Humira

300,00 610,00 

Therapeutic TNF-α-antibody from the original Humira commercial drug targeting the TNF-α-antigen, also referred to as Humira antibody.

Gazyvaro

300,00 748,00 

Therapeutic CD20-antibody from the original Gazyvaro commercial drug targeting the CD20-antigen, also referred to as Gazyvaro antibody.

Keytruda

300,00 825,00 

Therapeutic PD-1-antibody from the original Keytruda commercial drug targeting the PD-1-antigen, also referred to as Keytruda antibody.

Erbitux

273,00 300,00 

Therapeutic EGFR-antibody from the original Erbitux commercial drug targeting the EGFR-antigen, also referred to as Erbitux antibody.

Yervoynew

961,00 

Therapeutic CTLA4-antibody from the original commercial drug Yervoy targeting the CTLA4-antigen (CD152), also referred to as Iplimumab antibody. This antibody is available with the original certificate of analysis (CoA).

Perjetanew

633,00 

Therapeutic HER2-antibody from the original commercial drug Perjeta targeting the HER2-antigen, also referred to as Pertuzumab antibody. This antibody is available with the original certificate of analysis (CoA).

Imfinzi

197,00 

Therapeutic PD-L1-antibody from the original commercial drug Imfinzi targeting the PD-L1-antigen, also referred to as Durvalumab antibody.

Bavencio

301,00 

Therapeutic PD-L1-antibody from the original commercial drug Bavencio targeting the PD-L1-antigen, also referred to as Avelumab antibody.

Opdivo

299,00 300,00 

Therapeutic PD-1-antibody from the original Opdivo commercial drug targeting the PD-1-antigen, also referred to as Opdivo antibody.